A new study reveals that prolactin, a hormone often linked to breastfeeding, plays a significant role in heightened post-operative pain and chronic pain risk in women. Researchers have developed an antibody therapy, PL200,019, that targets prolactin and shows promise in reducing pain and opioid dependence in preclinical models, potentially paving the way for personalized medicine and improved surgical recovery for women.

Read the full article at https://www.paperleap.com/blog/articles/how-prolactin-influences-pain-and-what-can-be-done-about-it-0ccc2u